Director, Medical Affairs

Mavericks Wanted

When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on
 
In 2015, we pioneered a “moneyball for biotech” approach, pooling projects and promising early-stage research from academia together under one financial umbrella to reduce risk and unleash innovation. This model allows science and small teams of experts to lead the way. We build bridges to groundbreaking advancements in rare disease, and develop life-changing medicines for patients with unmet needs as fast as humanly possible. 
 
Together we define white space, push boundaries and empower people to solve problems. If you're someone who defies convention, join us and work alongside some of the most respected minds in the industry. Together, we'll ask "why not?" and help reengineer the future of biopharma. At BridgeBio, we value curiosity and experimentation—including the ethical & thoughtful use of AI to improve clarity, speed, and quality of work.

What You'll Do

As the Director, Medical Affairs, reporting into the Sr Director, Skeletal Dysplasia, you will help shape the future of care for individuals with skeletal dysplasias by developing and executing the medical strategy behind infigratinib’s development and launch. You will serve as the scientific voice connecting clinicians, researchers, advocacy groups, and internal teams, ensuring our medical insights drive smart decisions and meaningful progress. Your leadership will influence how QED educates, communicates, and engages the field. This is an opportunity to make a direct and lasting impact on a community with limited therapeutic options today.

Responsibilities

• Lead or co-lead advisory boards, symposia, and scientific forums that elevate understanding, spark collaboration, and inform strategy
• Build trusted partnerships with KOLs, clinical experts, and the research community to advance scientific and medical insight
• Serve as a key medical reviewer within MLR, guiding compliant and impactful scientific communications and post-marketing commitments
• Partner across Clinical Development, HEOR, Field Medical/MSL, Patient Advocacy, and Scientific Communications to ensure medical strategy and execution are aligned and launch-ready
• Represent QED at major scientific and professional meetings, sharing insights and identifying opportunities that support program growth
• Contribute to medical information initiatives, team training, publication strategy, and evaluation of external collaborations

Where You'll Work

This is either a hybrid role requiring in-office collaboration 2-3x per week in our San Francisco Office, or a U.S-based remote role that will require quarterly, or as needed visits to our San Francisco Office.

Travel up to 50% is expected for scientific congresses, KOL engagements, advisory boards, and key internal meetings.

Who You Are

• MD , PhD or NP with 5+ years of post-graduate experience and 3+ years in US Medical Affairs and/ or clinical development (pharma/biotech); clinical experience in pediatric rare disease/ skeletal dysplasia is a plus
• Experienced in pediatric rare diseases with deep understanding of genetics and mechanisms of genetic disease, skeletal dysplasia and launch experience preferred
• A scientific thinker who excels at translating complex science into clear, compelling strategy
• A collaborative leader who influences without direct authority and thrives in fast-paced environments
• Strong communicator with experience navigating regulatory frameworks relevant to medical affairs
• Able to travel up to 50% and legally authorized to work in the United States
• You have demonstrated curiosity and adaptability in adopting AI-powered tools and technologies

Rewarding Those Who Make the Mission Possible

We have high expectations for our team members. We make sure those working hard for patients are rewarded and cared for in return.